Another study70 showed that the m2/m2 genotype of CYP1A1 MspI polymorphism had a significantly elevated risk in oral cancer patients, but there was no significant relationship between this polymorphism and pharyngeal and laryngeal cancers that one review80 confirmed it. This evidence concerns the gene CYP1A1 and lip and oral cavity carcinoma.